RECRUITING

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.

Official Title

Enhancing Modulation Effects of Baduanjin Through Non-invasive Neuromodulation for Knee Osteoarthritis

Quick Facts

Study Start:2024-03-05
Study Completion:2028-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05839535

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Volunteers 45-75 years of age
  2. * Meet the Classification Criteria of the American College of Rheumatology for osteoarthritis of the right and/or left knee for at least the past 3 months;
  3. * Physically able to participate in the BDJ and stretching control education programs
  4. * Willing to complete the 12-week study
  5. * Can participate in MRI scan
  6. * Ability to read and understand English; English can be a second language provided that the patient feels he or she can understand all the questions used in the assessment measures
  1. * Has performed BDJ, Tai Chi, Yoga, other mind-body intervention, physical therapy, or routine exercise (running, cycling, etc.) regularly in the past year
  2. * Serious medical conditions limiting ability of patient to participate in the study, such as symptomatic cardiovascular disease, symptomatic pulmonary disease requiring supplemental oxygen, uncontrolled metabolic diseases, severe renal and liver disease
  3. * Has had intra-articular steroid injections or reconstructive surgery in the prior 3 months on the affected knee; any intra-articular hyaluronic acid injections in the previous 6 months
  4. * Patient Mini-Mental Status Examination score below 24 \[293\]
  5. * Unable to walk without a cane or other assistive device
  6. * The intent to undergo surgery during the time of involvement in the study
  7. * Plan to permanently relocate from the region during the trial period

Contacts and Locations

Study Contact

Jian Kong
CONTACT
617-7267893
jkong2@mgh.harvard.edu

Study Locations (Sites)

Massachusetts General Hospital
Charlestown, Massachusetts, 02129
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-05
Study Completion Date2028-08-31

Study Record Updates

Study Start Date2024-03-05
Study Completion Date2028-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Knee Osteoarthritis